Medical Engineering & Physics
Volume 28, Issue 7 , Pages 665-681 , September 2006

Model predictive glycaemic regulation in critical illness using insulin and nutrition input: A pilot study

  • X.W. Wong

      Affiliations

    • Department of Mechanical Engineering, College of Engineering, University of Canterbury, Christchurch, New Zealand
    • Corresponding Author InformationCorresponding author. Tel.: +64 21 2526258.
    • ,
  • J.G. Chase

      Affiliations

    • Department of Mechanical Engineering, College of Engineering, University of Canterbury, Christchurch, New Zealand
    • Christchurch School of Medicine and Health Science, University of Otago, Dunedin, Christchurch, New Zealand
    • ,
  • G.M. Shaw

      Affiliations

    • Department of Intensive Care, Christchurch Hospital, Christchurch, New Zealand
    • Christchurch School of Medicine and Health Science, University of Otago, Dunedin, Christchurch, New Zealand
    • ,
  • C.E. Hann

      Affiliations

    • Department of Mechanical Engineering, College of Engineering, University of Canterbury, Christchurch, New Zealand
    • ,
  • T. Lotz

      Affiliations

    • Department of Mechanical Engineering, College of Engineering, University of Canterbury, Christchurch, New Zealand
    • ,
  • J. Lin

      Affiliations

    • Department of Mechanical Engineering, College of Engineering, University of Canterbury, Christchurch, New Zealand
    • ,
  • I. Singh-Levett

      Affiliations

    • Department of Mechanical Engineering, College of Engineering, University of Canterbury, Christchurch, New Zealand
    • ,
  • L.J. Hollingsworth

      Affiliations

    • Department of Mechanical Engineering, College of Engineering, University of Canterbury, Christchurch, New Zealand
    • ,
  • O.S.W. Wong

      Affiliations

    • Christchurch School of Medicine and Health Science, University of Otago, Dunedin, Christchurch, New Zealand
    • ,
  • S. Andreassen

      Affiliations

    • Centre for Model-based Medical Decision Support, University of Aalborg, Aalborg, Denmark

Received 1 July 2005 ,Revised 6 October 2005 ,Accepted 31 October 2005.

References 

  1. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–778
  2. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345:1359–1367
  3. Mizock BA. Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab. 2001;15:533–551
  4. McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–124
  5. Patino JF, de Pimiento SE, Vergara A, Savino P, Rodriguez M, Escallon J. Hypocaloric support in the critically ill. World J Surg. 1999;23:553–559
  6. Weissman C. Nutrition in the intensive care unit. Crit Care. 1999;3:R67–R75
  7. Woolfson AM. Control of blood glucose during nutritional support in ill patients. Intensive Care Med. 1980;7:11–14
  8. Elia M, Ceriello A, Laube H, Sinclair AJ, Engfer M, Stratton RJ. Enteral nutritional support and use of diabetes-specific formulas for patients with diabetes: A systematic review and meta-analysis. Diabetes Care. 2005;28:2267–2279
  9. Krajicek BJ, Kudva YC, Hurley HA. Potentially important contribution of dextrose used as diluent to hyperglycemia in hospitalized patients. Diabetes Care. 2005;28:981–982
  10. Thorburn A, Litchfield A, Fabris S, Proietto J. Abnormal transient rise in hepatic glucose-production after oral glucose in non-insulin-dependent diabetic subjects. Diabetes Res. Clin. Pract. 1995;28:127–135
  11. Larsen MO, Rolin B, Wilken M, Carr RD, Svendsen O. High-fat high-energy feeding impairs fasting glucose and increases fasting insulin levels in the Gottingen minipig – results from a pilot study. In: Lipids and insulin resistance: the role of fatty acid metabolism and fuel partitioning, vol. 967. Annals of the New York Academy of Sciences, 2002. p. 414–23.
  12. Bistrian BR. Hyperglycemia and infection: Which is the chicken and which is the egg?. JPEN J Parenter Enteral Nutr. 2001;25:180–181
  13. Diringer MN. Improved outcome with aggressive treatment of hyperglycemia – Hype or hope?. Neurology. 2005;64:1330–1331
  14. Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med. 2003;31:359–366
  15. Krinsley JS. Decreased mortality of critically ill patients with the use of an intensive glycemic management protocol. Crit Care Med. 2003;31:A19
  16. Krinsley JS. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc. 2004;79:992–1000
  17. Hann CE, Chase JG, Lin J, Lotz T, Doran CV, Shaw GM. Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model. Comput Methods Program Biomed. 2005;77:259–270
  18. Chase JG, Shaw GM, Lin J, Doran CV, Hann C, Robertson MB, et al. Adaptive bolus-based targeted glucose regulation of hyperglycaemia in critical care. Med Eng Phys. 2005;27:1–11
  19. Rashid S, Shi ZQ, Niwa M, Mathoo JMR, Vandelangeryt M, Bilinski D, et al. beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs. Diabetes. 2000;49:253–262
  20. Rashid S, Niwa M, VanDelangeryt M, Mathoo J, Bilinski D, Vranic M. Improvement of impaired glucose clearance during stress in diabetes with hyperinsulinemia or beta-blockade. Diabetes. 1997;46:881
  21. Prigeon RL, Roder ME, Porte D, Kahn SE. The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique, Evidence for saturable insulin transport in humans. J Clin Invest. 1996;97:501–507
  22. Natali A, Gastaldelli A, Camastra S, Sironi AM, Toschi E, Masoni A, et al. Dose–response characteristics of insulin action on glucose metabolism: a non-steady-state approach. Am J Physiol Endocrinol Metab. 2000;278:E794–E801
  23. Mari A, Valerio A. A circulatory model for the estimation of insulin sensitivity. Control Eng Practice. 1997;5:1747–1752
  24. Beard JC, Bergman RN, Ward WK, Porte DJ. The insulin sensitivity index in nondiabetic man. Correlation between clamp-derived and IVGTT-derived values. Diabetes. 1986;35:362–369
  25. Caumo A, Vicini P, Zachwieja JJ, Avogaro A, Yarasheski K, Bier DM, et al. Undermodeling affects minimal model indexes: insights from a two-compartment model. Am J Physiol. 1999;276:E1171–E1193
  26. Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi-Benedetti M, Federici MO, et al. Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Measur. 2004;25:905–920
  27. Chee F, Fernando T, van Heerden PV. Closed-loop control of blood glucose levels in critically ill patients. Anaesth Intensive Care. 2002;30:295–307
  28. Doran CV, Hudson NH, Moorhead KT, Chase JG, Shaw GM, Hann CE. Derivative weighted active insulin control modelling and clinical trials for ICU patients. Med Eng Phys. 2004;26:855–866
  29. Doran CV. Modelling and control of hyperglycemia in critical care patients. Mechanical engineering. Christchurch, NZ: University of Canterbury; 2004;
  30. Kiwanuka E, Barazzoni R, Tessari P. Glucose kinetics and splanchnic uptake following mixed meal ingestion in cirrhotic-diabetic subjects. Diabetes Nutr Metab. 2001;14:315–324
  31. Wolfe RR, Glucose metabolism. In: Radioactive and stable isotope tracers in biomedicine: principles and practice of kinetic analysis. New York: Wiley-Liss; 1992. p. 283–315.
  32. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214–E223
  33. Thorsteinsson B, Fugleberg S, Feldt-Rasmussen B, Ellemann K, Binder C. Kinetics models for insulin disappearance from plasma in Type 1 diabetic patients. Pharmacol Toxicol. 1987;60:90–95
  34. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest. 1981;68:1456–1467
  35. Ellemann K, Thorsteinsson B, Fugleberg S, Feldt-Rasmussen B, Andersen OO, Gronbaek P, et al. Kinetics of insulin disappearance from plasma in cortisone-treated normal subjects. Clin Endocrinol (Oxf). 1987;26:623–628
  36. Kuehn L, Blundell T. In:  Schulster D,  Levitski A editor. Insulin and glucagons receptors in Cellular receptors for hormones and neurotransmitters. Chichester: John Wiley and Sons; 1980;p. 185–196
  37. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol. 1981;240:E630–E639
  38. Hovorka R, Shojaee-Moradie F, Carroll PV, Chassin LJ, Gowrie IJ, Jackson NC, et al. Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. Am J Physiol Endocrinol Metab. 2002;282:E992–E1007
  39. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev. 1985;6:45–86
  40. Furler SM, Kraegen EW, Smallwood RH, Chisholm DJ. Blood glucose control by intermittent loop closure in the basal mode: computer simulation studies with a diabetic model. Diabetes Care. 1985;8:553–561
  41. Transberg K, Hagander P, Thorell J. Disappearance of insulin in man: variation with the plasma insulin level. Acta Endocrinol (Copenh). 1981;97:391–397
  42. Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, et al. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J Clin Invest. 1997;100:2354–2361
  43. Radziuk J, McDonald TJ, Rubenstein D, Dupre J. Initial Splanchnic Extraction of Ingested Glucose in Normal Man. Metab Clin Exp. 1978;27:657–669
  44. Ludvik B, Nolan JJ, Roberts A, Baloga J, Joyce M, Bell JM, et al. A Noninvasive Method to Measure Splanchnic Glucose-Uptake after Oral Glucose-Administration. J Clin Invest. 1995;95:2232–2238
  45. Cummins AJ. Absorption of glucose and methionine from the human intestine. Influence of the glucose concentration in the blood and the intestinal lumen. J Clin Invest. 1952;31:928–937
  46. Consoli A. Role of liver in pathophysiology of NIddm. Diabetes Care. 1992;15:430–441
  47. Pehling G, Tessari P, Gerich JE, Haymond MW, Service FJ, Rizza RA. Abnormal meal carbohydrate disposition in insulin-dependent diabetes – Relative contributions of endogenous glucose-production and initial splanchnic uptake and effect of intensive insulin therapy. J Clin Invest. 1984;74:985–991
  48. Mari A, Stojanovska L, Proietto J, Thorburn AW. A circulatory model for calculating non-steady-state glucose fluxes. Validation and comparison with compartmental models,. Comput Methods Prog Biomed. 2003;71:269–281
  49. Steele R. Influence of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci. 1959;82:420–430
  50. Nielsen MF, Basu R, Wise S, Caumo A, Cobelli C, Rizza RA. Normal glucose-induced suppression of glucose production but impaired stimulation of glucose disposal in type 2 diabetes: evidence for a concentration-dependent defect in uptake. Diabetes. 1998;47:1735–1747
  51. Basu R, Basu A, Johnson CM, Schwenk WF, Rizza RA. Insulin dose-response curves for stimulation of splanchnic glucose uptake and suppression of endogenous glucose production differ in nondiabetic humans and are abnormal in people with type 2 diabetes. Diabetes. 2004;53:2042–2050
  52. Basu A, Basu R, Shah P, Vella A, Johnson CM, Jensen M, et al. Type 2 diabetes impairs splanchnic uptake of glucose but does not alter intestinal glucose absorption during enteral glucose feeding - Additional evidence for a defect in hepatic glucokinase activity. Diabetes. 2001;50:1351–1362
  53. Firth R, Bell P, Marsh H, Hansel I, Rizza R. Post-prandial hyperglycemia in patients with non-insulin dependent diabetes mellitus: role of hepatic and extrahepatic tissues. J Clin Invest. 1985;74:1525–1532
  54. Arleth T, Andreassen S, Orsini Federici M, Timi A, Massi-Benedetti M. A model of glucose absorption from mixed meals, Modelling and Control of Biomedical Systems 2000 (including Biological Systems): A Proceedings Volume from the 4th IFAC Symposium, 2000. E. Carson and E. Salzsieder, Elsevier Science Limited, Oxford, p. 307–312.
  55. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc. 2003;78:1471–1478
  56. Novartis, RESOURCE® Diabetic Nutrition Information. US: Novartis Medical Nutrition; 2005.
  57. Rubinson L, Diette GB, Song X, Brower RG, Krishnan JA. Low caloric intake is associated with nosocomial bloodstream infections in patients in the medical intensive care unit. Crit Care Med. 2004;32:350–357
  58. Weitgasser R, Gappmayer B, Pichler M. Newer portable glucose meters – Analytical improvement compared with previous generation devices?. Clin Chem. 1999;45:1821–1825

PII: S1350-4533(05)00227-4

doi: 10.1016/j.medengphy.2005.10.015

Medical Engineering & Physics
Volume 28, Issue 7 , Pages 665-681 , September 2006

Article Tools

* Image Usage & Resolution